The pleiotropic CLEC10A: implications for harnessing this receptor in the tumor microenvironment.
Nadia L van der MeijsMaria Alejandra TravecedoFilipa MarceloSandra J van VlietPublished in: Expert opinion on therapeutic targets (2024)
To translate this to a successful CLEC10A-mediated immunotherapy with limited tumor-promoting capacities, finding the right ligand presentation and adjuvant combination will be key.